Judge: Drug Company's Alleged Misstatements In Stock-Drop Suit Not Actionable
BOSTON — Statements issued by a pharmaceutical company and certain current and former executive officers regarding the timing of topline results for a Phase 3 clinical test for a renal cancer...To view the full article, register now.
Already a subscriber? Click here to view full article